Pain Perception During Vulvar Biopsy
A Comparison of Pain Perception Using Topical EMLA Cream Versus Lidocaine Injection for Vulvar Biopsy: a Randomized Controlled Trial
Sponsor: Duke University
Terminated
interim analysis produced significant results, so we ended enrollment
This PHASE4 trial investigates Any Condition Requiring Vulvar Biopsy and is currently terminated or withdrawn. Duke University leads this study, which shows 11 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE4
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE4
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE4
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE4
-
Feb 2020 — Jan 2021 [monthly]
Terminated PHASE4
-
Dec 2019 — Feb 2020 [monthly]
Terminated PHASE4
-
Jul 2019 — Dec 2019 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
-
Nov 2018 — Jul 2019 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Sep 2018 — Nov 2018 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Duke University
For direct contact, visit the study record on ClinicalTrials.gov .